Search
Now showing items 1-3 of 3
Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis
(Public Library of Science, 2012-06)
Background: In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid ...
Health service delay and associated factors among pulmonary tuberculosis patients presenting to Mulago Hospital: a cross sectional study.
(2009-10)
Delay in the diagnosis of pulmonary tuberculosis (PTB) is common in many countries in sub-Saharan Africa. Timely diagnosis of active TB is particularly crucial to minimise not only morbidity and mortality in the community, ...
Comparison of models for analysis of time to loss to follow up and associated risk factors among patients receiving tuberculosis treatment from Mbarara Regional Referral Hospital, Uganda
(Makerere University, 2023)
Background: Tuberculosis (TB) remains the top infectious killer worldwide. In Uganda, incidence of TB was reported at 200 per 100,000 people per year. Loss to follow up (LTFU) on TB treatment was 13% in Uganda and 10% in ...